Management of Malignant Ovarian Germ Cell Tumors
- 1 August 2011
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Obstetrical & Gynecological Survey
- Vol. 66 (8), 507-514
- https://doi.org/10.1097/ogx.0b013e318234ede9
Abstract
Malignant ovarian germ cell tumors are rare, highly curable cancers of young women. The majority of patients can be cured with either fertility-preserving surgery alone or a combination of surgery and chemotherapy. Relapses occur in 10% to 20% of patients, and the significant proportion of them can be salvaged with chemotherapy. There is no evidence that treatment for malignant ovarian germ cell tumors will adversely affect menstrual or reproductive functions, increase future pregnancy loss, or increase the risk of congenital malformations of the fetus. Late effects, such as secondary leukemia, from chemotherapy are reported but rare. Obstetricians & Gynecologists and Family Physicians. After completing this CME activity, physicians should be better able to diagnose ovarian germ cell tumors, outline management of malignant ovarian germ cell tumors, and understand the impact of treatment on fertility and late effects.Keywords
This publication has 71 references indexed in Scilit:
- Chronic Physical Effects and Health Care Utilization in Long-Term Ovarian Germ Cell Tumor Survivors: A Gynecologic Oncology Group StudyJournal of Clinical Oncology, 2009
- A review of the close surveillance policy for stage I female germ cell tumors of the ovary and other sitesInternational Journal of Gynecologic Cancer, 2008
- Phase II Study of Paclitaxel Plus Gemcitabine Salvage Chemotherapy for Germ Cell Tumors After Progression Following High-Dose Chemotherapy With Tandem TransplantJournal of Clinical Oncology, 2007
- Malignant Ovarian Germ Cell Tumors: Identification of Novel Prognostic Markers and Long-Term Outcome After Multimodality TreatmentJournal of Clinical Oncology, 2006
- A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumoursAnnals of Oncology, 2005
- Malignant germ cell tumors of the ovaryPublished by Ovid Technologies (Wolters Kluwer Health) ,2000
- Ovarian hepatoid yolk sac tumours: morphological, immunohistochemical and ultrastructural featuresHistopathology, 1999
- Chemotherapy for ovarian germ cell tumoursEuropean Journal of Cancer, 1996
- The Influence of Grade on the Outcome of Stage I Ovarian Immature (Malignant) Teratomas and the Reproducibility of GradingInternational Journal of Gynecological Pathology, 1994
- Second-Look Laparotomy in Ovarian Germ Cell Tumors: The Gynecologic Oncology Group ExperienceGynecologic Oncology, 1994